• J. Am. Acad. Dermatol. · Apr 2010

    Review

    Systematic review of the safety of topical corticosteroids in pregnancy.

    • Ching-Chi Chi, Shu-Hui Wang, Gudula Kirtschig, and Fenella Wojnarowska.
    • Department of Dermatology, Chang Gung Memorial Hospital-Chiayi, Chiayi, Taiwan.
    • J. Am. Acad. Dermatol. 2010 Apr 1; 62 (4): 694-705.

    BackgroundPregnant women may have skin conditions that require topical corticosteroids. However, little is known about their safety in pregnancy.ObjectiveWe sought to evaluate the available evidence concerning the safety of topical corticosteroids in pregnancy.MethodsWe systematically searched 17 databases and trial registers, and contacted pharmaceutical companies. Randomized controlled trials and cohort studies of topical corticosteroids in pregnant women, and case-control studies comparing maternal exposure to topical corticosteroids between patients and control subjects were included. The Newcastle-Ottawa Scale was used for quality assessment of included studies.ResultsSeven studies, including two cohort and five case-control studies, were included. Most studies did not find significant associations of topical corticosteroids with congenital abnormality, preterm delivery stillbirth, and mode of delivery. One study found a significant association between first-trimester use of topical corticosteroids and orofacial cleft, and another study found a significant association between very potent topical corticosteroids and low birthweight.LimitationsThe available data were limited and mainly on orofacial cleft. The quality of evidence was generally low.ConclusionsCurrently limited and inconclusive data are unable to detect an association between topical corticosteroids and congenital abnormality, preterm delivery, or stillbirth. The current evidence shows no statistically significant difference between pregnant women who use and those who do not use topical corticosteroids. However, there does appear to be an association of very potent topical corticosteroids with low birthweight. Further cohort studies with comprehensive outcome measures, consideration of corticosteroid potency, dosage and indications, and a large sample size are needed.Copyright 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…